Patients’ perspectives can be integrated in health technology assessments: An exploratory analysis of CADTH common drug review

Research Involvement and Engagement

Volumn 2, Issue 1, 2016, Pages

  Berglas, Sarah ^a   Jutai, Lauren ^b   Mackean, Gail ^c   Weeks, Laura ^a  

^a CANADIAN AGENCY FOR DRUGS AND TECHNOLOGIES IN HEALTH   (Canada)

^b LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

CADTH; Common Drug Review; Evaluation; Health technology assessment; Patient engagement

Indexed keywords

EID: 85014861075     PISSN: None     EISSN: 20567529     Source Type: Journal    
DOI: 10.1186/s40900-016-0036-9     Document Type: Article

References (28)

1. Facey K, Boivin A, Gracia J, Hansen HP, Lo Scalzo A, Mossman J, Single A. Patients’ perspectives in health technology assessment: a route to robust evidence and fair deliberation. Int J Technol Assess Health Care. 2010; 26(3):334–40.
2. Facey K. Patient involvement in HTA: what added value? Pharmaceuticals Policy and Law. 2011;13:245–51.
3. Health Innovation Forum. Raising the bar on health system performance: patients as partners. http://www. healthinnovationforum.org/wp-content/uploads/2014/01/Patients-as-partners_2015.pdf. (2015) Accessed 6 Oct 2015.
4. Greenhalgh T, Snow R, Ryan S, Rees S, Salisbury H. Six ‘biases’ against patients and carers in evidence-based medicine. BMC Medicine. 2015;13:200.
5. Drummond M, Tarricone R, Torbica A. Assessing the added value of health technologies: reconciling different perspectives. Value Health. 2013;16:S7–13.
6. Daniels N. J Decisions about access to health care and accountability for reasonableness. Urban Health. 1999;76(2):176–91.
7. Delbanco T, Berwick D, Boufford J, Edgman-Levitan S, Ollenschläger G, Plamping D, Rockefeller R. Healthcare in a land called PeoplePower: nothing about me without me. Health Expect. 2001;4(3):144–50.
8. Pivik J, Rode E, Ward C. A consumer involvement model for health technology assessment in Canada. Health Policy. 2004;69:253–68.
9. CADTH. Five years of patient engagement. https://www.cadth.ca/news/update-patient-groups-june-2015 (2015). Accessed 6 Oct 2015.
10. CADTH. Patient input templates. https://www.cadth.ca/about-cadth/what-we-do/products-services/cdr/patient-input/patient-input-templates (2010). Accessed 30 Mar 2016.
11. CADTH Common Drug Review. Procedure for the CADTH Common Drug Review. https://www.cadth.ca/about-cadth/what-we-do/products-services/cdr (2014). Accessed 6 Oct 2015.
12. Staniszewska S, Brett J, Mockford C, Barber R. The GRIPP checklist: strengthening the quality of patient and public involvement reporting in research. Int J Technol Assess Health Care. 2011;27(4):391–9.
13. Dipankui MT, Gagnon MP, Desmartis M, Légaré F, Piron F, Gagnon J, Rhiands M, Coulombe M. Evaluation of patient involvement in a health technology assessment. Int J Technol Assess Health Care. 2015;31(3):166–70.
14. Best Medicines Coalition. Health technology assessment in Canada: improving the system and ensuring the patient voice is heard. http://www.bestmedicines.ca/node/166 (2014). Accessed 8 Oct 2015.
15. Wong-Rieger D. Are you listening to me? Patient input on drug reviews. https://www.cadth.ca/cadth-symposium-archives/2013/program-and-presentations (2013). Accessed Oct 8, 2015.
16. Dionne PA, Weicker S, Remple V, Tran T. Role of patient input in the CEDAC drug reimbursement decision making process. [Abstract]. The Journal of the International Society for Pharmacoeconomic and Outcomes Research. 2014; 17(3):A10. Presented at ISPOR 19th Annual International Meeting; May 31-June 4, 2014; Montréal, QC, Canada.
17. Porter ME. What is value in health care? N Engl J Med. 2010;363(26):2477–81.
18. CADTH patient community liaison forum. https://www.cadth.ca/cadth-patient-community-liaison-forum (2013). Accessed Mar 30, 2016.
19. Rycroft-Malone J, Seers K, Titchen A, Harvey G, Kitson A, McCormack B. What counts as evidence in evidence-based practice? J Adv Nurs. 2004;47(1):81–90.
20. International Network of Agencies for Health Technology Assessment (INAHTA). What is Health Technology Assessment (HTA)? http://www.inahta.org/Accessed 8 Oct 2015.
21. Horne R, Chapman SCE, Parham R, Freemantle N, Forbes A, et al. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity-concerns framework. PLoS One. 2013;8(12), e80633.
22. CADTH. (2015) Common drug review clinical review report. https://www.cadth.ca/sites/default/files/cdr/clinical/SR0346_TudorzaGenuair_CL_Report.pdf. Accessed 30 Mar 2016.
23. Stanley K, Doherty C. It’s not evidence, it’s insight: bringing patients’ perspectives into health technology appraisal at NICE. Research Involvement and Engagement. 2016;2:4.
24. James Lind Alliance: priority setting partnerships. http://www.jla.nihr.ac.uk/Accessed 8 Oct 2015.
25. COMET (Core Outcome Measures in Effectiveness Trials) Initiative: COMET Database. http://www.comet-initiative. org/Accessed8 Oct 2015.
26. Patient and Community Engagement Research (PACER). http://www.pacerinnovates.ca/Accessed 8 Oct 2015.
27. CADTH Scientific Advice: patient involvement in scientific advice. https://scientificadvice.cadth.ca/Accessed 8 Oct 2015.
28. CADTH. Cate Dobhran, CDEC member; 2011. Available from: https://youtu.be/kop9yWq6tN0?t=59 Accessed 22 Oct 2015.